An alteration in the chemical structure of the aortic wall induced by a finite period of growth inhibition.
D000818:Animals; D001012:Aorta, Abdominal / Q000032:analysis* / Q000187:drug effects / Q000254:growth & development; D001013:Aorta, Thoracic / Q000032:analysis* / Q000187:drug effects / Q000254:growth & development; D003094:Collagen / Q000032:analysis*; D004247:DNA / Q000032:analysis*; D004549:Elastin / Q000032:analysis*; D005260:Female; D006128:Growth / Q000187:drug effects*; D007668:Kidney / Q000032:analysis; D002955:Leucovorin / Q000494:pharmacology; D008099:Liver / Q000032:analysis; D008297:Male; D008727:Methotrexate / Q000494:pharmacology; D011247:Pregnancy; D012313:RNA / Q000032:analysis*; D051381:Rats
D012313:RNA; D003094:Collagen; D004247:DNA; D004549:Elastin; D002955:Leucovorin; D008727:Methotrexate